GLP-1 Medications for Weight Loss Contact Us Today to Schedule your First Appointment and Experience the Benefits
OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells
Huang C, Yi P, Zhu M, et al
Conceptualization: AD, EG Methodology: AD, EG, AG, HS, JC, MLV, PLC, CC, TG, OF, AMK, CL, BJ Investigation: AD, EG, AG, MLV, HS, TG, OF, DK Visualization: AD, EG, AG, HS Funding acquisition: AD, RB, GWM Project administration: AD, RB, GWM Supervision: AD Writing original draft: AD, EG Writing review & editing: AD, EG, AG, HS, JC, MLV, PLC, CC, TG, OF, AMK, CL, DK, RB, GWM Competing interests Authors declare that they have no competing interests